"Ecologic niche" therapy for Crohn's disease with adjunctive rifaximin antibiotic treatment followed by Flora-Q probiotic maintenance therapy

Am J Gastroenterol. 2008 Jan;103(1):251-2. doi: 10.1111/j.1572-0241.2007.01562_13.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anti-Infective Agents / therapeutic use*
  • Crohn Disease / drug therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Probiotics / therapeutic use*
  • Remission Induction
  • Rifamycins / therapeutic use*
  • Rifaximin

Substances

  • Anti-Infective Agents
  • Rifamycins
  • Rifaximin